Caplin Point Laboratories Ltd
company logo

Caplin Point Laboratories Ltd

Pharmaceuticals
Mid Cap

-

- (0%)


Caplin Point Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Caplin Point Laboratories Ltd Fundamentals

11,403.82Cr

24.95

4.92

-

60.13

0.17%

304.66

i buttonClick here to know more about Fundamentals

Caplin Point Laboratories Ltd Financials

Caplin Point Laboratories Ltd Financialsright-arrow

Caplin Point Laboratories Ltd Shareholding Pattern

Caplin Point Laboratories Ltd Delivery and Volume

About Caplin Point Laboratories Ltd

Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990. The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded pro

-

1990

CAPLIPOINT

NameDesignation
C C PaarthipanChairman & Non Executive Dir.
D SathyanarayananIndependent Non Exe. Director
C K GariyaliIndependent Director
Deenadayalan SingaramIndependent Non Exe. Director
R NagendranIndependent Non Exe. Director
Sridhar GanesanNon Independent Executive Director / MD
News and Events...

Similar Stocks

What's Trending

Caplin Point Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Caplin Point Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Caplin Point Laboratories Ltd's share price is ₹1497.65 as of 2024-07-19.
Caplin Point Laboratories Ltd's P/E ratio is 24.95 times as of 2024-07-19.
Caplin Point Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 4.92, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Caplin Point Laboratories Ltd's market capitalization is ₹11403.82 Cr as on 2024-07-19.
The current financial records of Caplin Point Laboratories Ltd show a 22.63% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Caplin Point Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹504.81, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Caplin Point Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Caplin Point Laboratories Ltd's 52-week high and low as of 2024-07-19 are ₹1523 and ₹1461.1, respectively.